MCA17-1 is an anti-liver fibrosis agent that demonstrates enhanced bioactivity compared to the positive control obeticholic acid (OCA). This compound serves as a valuable tool in research aimed at understanding liver fibrosis mechanisms and developing therapeutic strategies. Its superior efficacy positions MCA17-1 as a key candidate for studies focused on liver health and potential fibrosis reduction.
MCA17-1 is an anti-liver fibrosis agent that demonstrates enhanced bioactivity compared to the positive control obeticholic acid (OCA). This compound serves as a valuable tool in research aimed at understanding liver fibrosis mechanisms and developing therapeutic strategies. Its superior efficacy positions MCA17-1 as a key candidate for studies focused on liver health and potential fibrosis reduction.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
